LOSI, Lorena
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 21.871
EU - Europa 14.619
AS - Asia 8.982
SA - Sud America 1.211
AF - Africa 170
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 9
Totale 46.877
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 21.573
IT - Italia 7.135
GB - Regno Unito 3.250
SG - Singapore 3.173
CN - Cina 2.268
HK - Hong Kong 1.024
BR - Brasile 905
VN - Vietnam 891
SE - Svezia 840
DE - Germania 753
FR - Francia 418
FI - Finlandia 412
UA - Ucraina 371
RU - Federazione Russa 367
NL - Olanda 326
BD - Bangladesh 290
TR - Turchia 278
KR - Corea 203
IN - India 200
BG - Bulgaria 154
CA - Canada 142
ID - Indonesia 134
AR - Argentina 117
MX - Messico 92
AL - Albania 80
PL - Polonia 78
ES - Italia 73
IQ - Iraq 73
AE - Emirati Arabi Uniti 68
JP - Giappone 68
ZA - Sudafrica 56
BE - Belgio 49
PK - Pakistan 48
IE - Irlanda 47
LT - Lituania 43
RO - Romania 43
CL - Cile 37
MY - Malesia 36
EC - Ecuador 35
CH - Svizzera 32
UZ - Uzbekistan 30
CO - Colombia 29
PH - Filippine 25
VE - Venezuela 24
MA - Marocco 22
CZ - Repubblica Ceca 20
NP - Nepal 19
PY - Paraguay 19
IL - Israele 18
KE - Kenya 18
JO - Giordania 17
LV - Lettonia 17
SA - Arabia Saudita 16
UY - Uruguay 16
AT - Austria 15
PE - Perù 15
EG - Egitto 14
DK - Danimarca 13
PT - Portogallo 13
TH - Thailandia 13
TN - Tunisia 13
BO - Bolivia 12
DZ - Algeria 12
AU - Australia 11
BY - Bielorussia 11
ET - Etiopia 11
IR - Iran 11
KZ - Kazakistan 11
TW - Taiwan 11
AZ - Azerbaigian 10
CR - Costa Rica 9
GR - Grecia 9
JM - Giamaica 8
PS - Palestinian Territory 8
DO - Repubblica Dominicana 7
GT - Guatemala 7
KG - Kirghizistan 7
MD - Moldavia 7
NO - Norvegia 7
SI - Slovenia 7
HU - Ungheria 6
PA - Panama 6
RS - Serbia 6
BZ - Belize 5
PR - Porto Rico 5
QA - Qatar 5
LK - Sri Lanka 4
TT - Trinidad e Tobago 4
XK - ???statistics.table.value.countryCode.XK??? 4
AO - Angola 3
BA - Bosnia-Erzegovina 3
BB - Barbados 3
CG - Congo 3
EE - Estonia 3
EU - Europa 3
GA - Gabon 3
GE - Georgia 3
HN - Honduras 3
LB - Libano 3
MT - Malta 3
Totale 46.822
Salva come PNG Salva come JPEG
Città #
Southend 2.496
Singapore 2.037
Ashburn 1.813
Santa Clara 1.744
Fairfield 1.665
Woodbridge 1.129
Hong Kong 1.009
Chicago 1.004
Chandler 940
Houston 830
San Jose 727
Jacksonville 683
Los Angeles 668
Seattle 666
Wilmington 650
Rome 619
Hefei 601
Cambridge 592
Dearborn 574
Ann Arbor 532
Nyköping 485
Milan 480
Salt Lake City 441
Beijing 432
London 370
Modena 340
Council Bluffs 306
New York 298
Ho Chi Minh City 273
Helsinki 261
Elk Grove Village 215
Tampa 211
Hanoi 208
The Dalles 198
Seoul 192
Naples 184
San Diego 175
Shanghai 162
Princeton 157
Bologna 156
Dallas 154
Izmir 145
Sofia 140
Frankfurt am Main 134
Eugene 130
Sterling 125
Lauterbourg 122
Turin 114
Lancaster 113
Bari 112
Buffalo 105
São Paulo 103
Moscow 102
Florence 91
Jakarta 91
Palermo 86
Munich 83
Bremen 77
Cagliari 69
Columbus 67
Parma 67
Verona 66
Tirana 65
Des Moines 64
Detroit 64
Miami 64
Reggio Emilia 64
Orem 63
Phoenix 62
Dulles 60
Tokyo 59
Boardman 57
Perugia 57
Warsaw 55
Da Nang 53
Redwood City 51
Catania 50
Atlanta 49
Fremont 47
Toronto 47
Denver 44
Dublin 44
Padova 41
Pescara 41
Genoa 40
Chennai 38
Montreal 38
Brussels 37
Brooklyn 35
Stockholm 35
Kansas City 34
Trieste 34
Falls Church 33
Haiphong 33
Rio de Janeiro 33
Guangzhou 32
Pittsburgh 32
Brescia 31
Nanjing 29
Napoli 28
Totale 30.562
Salva come PNG Salva come JPEG
Nome #
Robbins e Cotran Atlante di Anatomia Patologica 6.459
Exome sequencing and bioinformatic approaches reveals rare sequence variants involved in cell signalling and elastic fibre homeostasis: new evidence in the development of ectopic calcification 515
Attenuated familial adenomatous polyposis and Muir-Torre syndrome linked to compound biallelic constitutional MYH gene mutations. 452
LonP1 Differently Modulates Mitochondrial Function and Bioenergetics of Primary Versus Metastatic Colon Cancer Cells 451
Wnt pathway, angiogenetic and hormonal markers in sporadic and familial adenomatous polyposis-associated juvenile nasopharyngeal angiofibromas (JNA) 450
Relationship between MUC5AC and altered expression of MLH1 protein in mucinous and non-mucinous colorectal carcinomas 442
Molecular genetic alterations and clinical features in early-onset colorectal carcinomas and their role for the recognition of hereditary cancer syndromes 437
BRAF mutations in multiple sebaceous hyperplasias of patients belonging to MYH-asociated polyposis pedigrees 426
K-ras and p53 mutations in hereditary non-polyposis colorectal cancers 409
KLF4 mediates the effect of 5-ASA on the b-catenin pathway in colon cancer cells 408
Prognostic value of Dworak grade of regression (GR) in patients with rectal carcinoma treated with preoperative radiochemotherapy 406
Value of MLH1 and MSH2 mutations in the appearance of Muir-Torre syndrome phenotype in HNPCC patients presenting sebaceous gland tumors or Keratoacanthomas 406
Silencing of mitochondrial Lon protease deeply impairs mitochondrial proteome and function in colon cancer cells. 404
DNA methylation profiling of esophageal adenocarcinoma using Methylation Ligation-dependent Macroarray (MLM) 404
Cytogenetic abnormalities and clinical features in a patient cohort affected by three or more synchronous or metachronous primitive malignancies. 401
Assessment of K-ras, Smad4 and p53 gene alterations in colorectal metastases and their role in the metastatic process 399
Different phenotypes in Muir-Torre Syndrome: clinical and biomolecular characterization in two italian families 391
K-ras and p53 mutations in human colorectal aberrant crypt foci 390
Microsatellite instability in multiple colorectal tumors 385
Conformational Propensity and Biological Studies of Proline Mutated LR Peptides Inhibiting Human Thymidylate Synthase and Ovarian Cancer Cell Growth 384
Brooke-Spiegler syndrome: Report of two cases not associated with a mutation in the CYLD and PTCH tumor-suppressor genes 383
Subcellular localization of beta-catenin and APC proteins in colorectal preneoplastic and neoplastic lesions RID B-2583-2012 382
Down-regulation of μ-protocadherin expression is a common event in colorectal carcinogenesis 382
Repurposing of drugs targeting yap-tead functions 376
Aetiology of colorectal cancer and relevance of monogenic inheritance. 373
Expression of μ-protocadherin is negatively regulated by the activation of the β-catenin signaling pathway in normal and cancer colorectal enterocytes 373
Molecular screening for Hereditary Non Polyposis Colorectal Cancer (HNPCC): a prospective, population-based study 369
Malignant melanoma in patients with hereditary nonpolyposis colorectal cancer 368
A mononucleotide markers panel to identify hMLH1/hMSH2 germline mutations 363
Proteomic and bioinformatic studies for the characterization of response to pemetrexed in platinum drug resistant ovarian cancer 363
Aberrant crypt foci in patients with colorectal cancer 362
Preoperative Therapy for Lower Rectal Cancer and Modifications in Distance From Anal Sphincter 361
Incidence and survival of patients with Dukes' A (stages T1 and T2) colorectal carcinoma: a 15-year population-based study. 361
Staging and survival of colorectal cancer: are we making progress? The 14-year experience of a Specialized cancer Registry 360
Argyrophilic nucleolar organizer regions and bromodeoxyuridine and h3-thymidine labelling indices in colorectal cancer 358
Biological parameters determining the clinical outcome of autologous cultures of limbal stem cells 358
Frequency of constitutional MSH6 mutations in a consecutive series of families with clinical suspicion of HNPCC. 354
A Peptidic Thymidylate-Synthase Inhibitor Loaded on Pegylated Liposomes Enhances the Antitumour Effect of Chemotherapy Drugs in Human Ovarian Cancer Cells 348
Identification of subjects at risk for colorectal carcinoma through a test based on K-ras determination in the stool 347
Promoter Methylation and Down-regulated Expression of the TBX15 Gene in Ovarian Carcinoma 346
Involvement of epigenetic modification of TERT promoter in response to all-trans retinoic acid in ovarian cancer cell lines 346
Immunohistochemical expression of MYH protein can be used to identify patients with MYH-associated polyposis 343
Prognostic significance of K-ras mutations in colorectal carcinoma. 341
Frequency and clinical features of multiple tumors of the large bowel in the general population and in patients with hereditary colorectal carcinoma 340
Loss of Smad4 expression predicts liver metastasis in human colorectal cancer 337
Histology of aberrant crypt foci in the human colon 335
Expression of p53 protein in prostate cancers of different histologic types. 335
Genomic instability and target gene mutations in colon cancers with different degrees of allelic shifts 334
Distinct DNA Methylation Profiles in Ovarian Tumors: Opportunities for Novel Biomarkers 330
Clinico-pathological and biomolecular findings in Italian patients with multiple cutaneous neurofibromas. 325
Preclinical study for treatment of hypospadias by advanced therapy medicinal products 323
Role of evaluating tumor‑infiltrating lymphocytes, programmed death‑1 ligand 1 and mismatch repair proteins expression in malignant mesothelioma 323
Biologic characterization of Hereditary Non-Polyposis Colorectal Cancer. Nuclear ploidy, AgNOR count, microvessel distribution, oncogene expression, and grade-related parameters. 322
Identification of Muir-Torre Syndrome among patients with sebaceous tumors and keratoacanthomas: role of clinical features, microsatellite instability and immunohistochemistry 320
Stability of K-ras mutations throughout the natural history of human colorectal cancer. 315
Primary mucinous (so-called colloid) carcinomas of the lung - A clinicopathologic and immunohistochemical study with special reference to CDX-2 homeobox gene and MUC2 expression 312
MELANOSIS (PIGMENTED MELANOCYTOSIS) OF THE PROSTATE GLAND. 310
Deep learning techniques for detecting preneoplastic and neoplastic lesions in human colorectal histological images 310
Folic Acid-Peptide Conjugates Combine Selective Cancer Cell Internalization with Thymidylate Synthase Dimer Interface Targeting 310
Human Thymidylate Synthase Inhibitors Halting Ovarian Cancer Growth 307
Loss of expression of μ-protocadherin and protocadherin-24 in sporadic and hereditary nonpolyposis colorectal cancers 304
Paneth and argyrophil cells in prostatic carcinoma. 303
Microsatellite instability and colorectal cancer prognosis. 302
Oxaliplatin plus leucovorin and 5-fluorouracil (FOLFOX-4) as a salvage chemotherapy in heavily-pretreated platinum-resistant ovarian cancer 301
Desmoplastic melanoma: a challenge for the oncologist 295
Clinical features, frequency and prognosis of Dukes' a colorectal carcinoma: A population-based investigation 295
Trend of incidence, subsite distribution and staging of colorectal neoplasms in the 15-year experience of a specialised cancer registry. 290
Evolution of intratumoral genetic heterogeneity during colorectal cancer progression 288
Destabilizers of the thymidylate synthase homodimer accelerate its proteasomal degradation and inhibit cancer growth 286
Prognostic significance of histological features and biological parameters in stage I (pT1 and pT2) colorectal adenocarcinoma 286
Incidence and clinical impact of sterilized disease and minimal residual disease after preoperative radiochemotherapy for rectal cancer 285
Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells 279
Leser-Trélat syndrome in patients affected by six multiple metachronous primitive cancers. 275
Gastrointestinal stromal tumor and other primary metachronous and synchronous neoplasms as a suspicious criterion for syndromic setting 274
p16 immunohistochemistry of multiple primary melanomas as screening to identify Familial Melanoma Syndrome 274
Colorectal carcinoma in different age groups: A population based investigation 273
Prognostic value of "Dworak" tumor regression grade (TRG) after pre-operative chemo-radiotherapy in rectal cancer (RC) 273
Regenerative Medicine of Epithelia: Lessons From the Past and Future Goals 272
Diagnosis of hereditary non-polyposis colorectal cancer (HNPCC) [2] (multiple letters) 270
Alternative marker panel for microsatellite instability analysis in detection of constitutional MLH1 and MSH2 mutations. 269
O6-methylguanine-DNA methyltransferase promoter hypermethylation in colorectal carcinogenesis 268
Genetic testing among high-risk individuals in families with hereditary non polyposis colorectal cancer 261
Biological characterization of mucinous carcinoma of the colon and rectum 259
L'immunoistochimica delle proteine del mismatch repair può essere un utile test per identificare i pazienti HNPCC? 258
Malignant peritoneal mesothelioma in a woman with bilateral ovarian serous borderline tumour: Potential interactions between the two diseases 255
SOX2 Is a Univocal Marker for Human Oral Mucosa Epithelium Useful in Post-COMET Patient Characterization 251
Can immunohistochemistry improve the pathological diagnosis of placenta accreta spectrum (PAS) disorders? 250
CDX-2 homeobox gene and MUC2 expression identifies true mucinous (so-called colloid) carcinoma of the lung and justifies its indolent outcome 250
High Expression of hTERT and stemness genes in BORIS/CTCFL positive cells isolated from embryonic cancer cells 244
Alternative marker panel for Microsatellite Instability analysis in deection of contitutional MLH1 and MSH2 mutations. 243
Selection of patients with germline MLH1 mutated Lynch syndrome by determination of MLH1 methylation and BRAF mutation. 240
TERT promoter methylation and protein expression as predictive biomarkers for recurrence risk in patients with serous borderline ovarian tumours 240
Inhibition of ERK1/2 signaling prevents bone marrow fibrosis by reducing osteopontin plasma levels in a myelofibrosis mouse model 239
Myxoid metastases of melanoma: report of three cases and review of the literature 232
Cadherins down-regulation: towards a better understanding of their relevance in colorectal cancer 229
Serum Mass Spectrometry Proteomics and Protein Set Identification in Response to FOLFOX-4 in Drug-Resistant Ovarian Carcinoma 228
Pigment epithelial-derived factor: a new player in dermal elastic fibre calcification? 228
Evidence for mitochondrial Lonp1 expression in the nucleus 228
Tumour spectrum in hereditary non-polyposis colorectal cancer (HNPCC) and in families with "suspected HNPCC". A population-based study in Northern Italy. Colorectal Cancer Study Group. 227
Survival for colon and rectal cancer in a population-based cancer registry 227
Totale 38.775
Salva come PNG Salva come JPEG
Categoria #
all - tutte 173.130
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 173.130
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021223 0 0 0 0 0 0 0 0 0 0 0 223
2021/20223.358 134 361 305 241 124 176 224 201 359 225 649 359
2022/20233.584 377 366 236 330 371 456 148 356 401 119 215 209
2023/20243.619 187 202 247 363 571 310 287 376 152 288 262 374
2024/20258.195 314 144 308 676 1.443 1.094 640 541 969 413 725 928
2025/202615.716 813 550 917 2.524 4.435 907 1.425 607 1.269 1.120 896 253
Totale 47.114